Literature DB >> 29902415

Synthesis of newly functionalized 1,4-naphthoquinone derivatives and their effects on wound healing in alloxan-induced diabetic mice.

Silvia Helena Cardoso1, Cleidijane Rodrigues de Oliveira2, Ari Souza Guimarães2, Jadiely Nascimento2, Julianderson de Oliveira Dos Santos Carmo3, Jamylle Nunes de Souza Ferro3, Ana Carolina de Carvalho Correia3, Emiliano Barreto4.   

Abstract

Naphthoquinone derivatives have various pharmacological properties. Here, we describe the synthesis of new 1,4-naphthoquinone derivatives inspired by lawsone and β-lapachone and their effects on both migration of fibroblasts in vitro and dermal wound healing in diabetic mice. NMR and FTIR spectroscopy aided characterization of chemical composition and demonstrated the molecular variations after the synthesis of four different derivatives, namely 2-bromo-1,4-naphthoquinone (termed derivative S3), 2-N-phenylamino-1,4-naphthoquinone (derivative S5), 2-N-isonicotinoyl-hydrazide-1,4-naphthoquinone (derivative S6), and 1-N-isonicotinoyl-hydrazone-[2-hydroxy-3-(3-methyl-2-butenyl)]-1,4-naphthoquinone (derivative S7). Our results indicate that derivatives S3, S5, S6 and S7 were non-toxic to the 3T3 fibroblast cell line. In scratch assays, derivatives S3 and S6, but not S5 or S7, stimulated the migration of fibroblasts. Compared with untreated diabetic mice, S3, S6 and S7 treatments accelerated wound closure. However, derivative S3 was optimal for the stimulation of epithelization, thereby increasing the number of keratinocyte layers and blood vessels, and reducing diffuse cellular infiltration, compared to derivatives S6 and S7. Our results suggest that novel 1,4-naphthoquinone derivatives promote fibroblast migration and accelerate wound closure under diabetic conditions.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes; Naphthoquinone derivatives; Wound healing

Mesh:

Substances:

Year:  2018        PMID: 29902415     DOI: 10.1016/j.cbi.2018.06.007

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  5 in total

1.  Novel Solid Dispersions of Naphthoquinone Using Different Polymers for Improvement of Antichagasic Activity.

Authors:  Verônica da Silva Oliveira; Elen Diana Dantas; Anna Thereza de Sousa Queiroz; Johny Wysllas de Freitas Oliveira; Marcelo de Sousa da Silva; Patricia Garcia Ferreira; Fernando de Carvalho da Siva; Vitor Francisco Ferreira; Ádley Antonini Neves de Lima
Journal:  Pharmaceutics       Date:  2020-11-24       Impact factor: 6.321

2.  Lapachol-Induced Upregulation of Sirt1/Sirt3 is linked with Improved Skin Wound Healing in Alloxan-induced Diabetic Mice.

Authors:  Shaheen Bibi; Fayyaz Ahmad; Muhammad Rizwan Alam; Muhammad Ansar; Kim Sun Yeou; Hussain Mustatab Wahedi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

Review 3.  Systematic review and meta-analysis of mouse models of diabetes-associated ulcers.

Authors:  Pacific Huynh; James Phie; Smriti Murali Krishna; Jonathan Golledge
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

4.  Uvaol Improves the Functioning of Fibroblasts and Endothelial Cells and Accelerates the Healing of Cutaneous Wounds in Mice.

Authors:  Julianderson Carmo; Polliane Cavalcante-Araújo; Juliane Silva; Jamylle Ferro; Ana Carolina Correia; Vincent Lagente; Emiliano Barreto
Journal:  Molecules       Date:  2020-10-28       Impact factor: 4.411

5.  Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial-Mesenchymal Transition and Migration in A549 Cells.

Authors:  Rodrigo Santos Aquino de Araújo; Julianderson de Oliveira Dos Santos Carmo; Simone Lara de Omena Silva; Camila Radelley Azevedo Costa da Silva; Tayhana Priscila Medeiros Souza; Natália Barbosa de Mélo; Jean-Jacques Bourguignon; Martine Schmitt; Thiago Mendonça de Aquino; Renato Santos Rodarte; Ricardo Olímpio de Moura; José Maria Barbosa Filho; Emiliano Barreto; Francisco Jaime Bezerra Mendonça-Junior
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.